What Biohaven Ltd.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 5 |
| Sells | 0 | 0 |
| Total trades | 0 | 17 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 4,463,841 |
| Disposed | 0 | 32,820 |
| Net activity | +0 | +4,431,021 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mehta Kishan | Director | Mar 17 | Gift · G | +17,342 | — | — | 17,342 |
| Mehta Kishan | Director | Mar 17 | Gift · G | −17,342 | — | — | 5,320 |
| Clark George C. | VP, Chief Accounting Officer | Jan 05 | Withheld — tax / exercise cost · F | −1,117 | $9.93 | −$11.1K | 66,978 |
| Clark George C. | VP, Chief Accounting Officer | Jan 05 | Exercise / conversion · M | +2,500 | — | — | 68,095 |
| Car Bruce | Chief Scientific Officer | Jan 05 | Withheld — tax / exercise cost · F | −2,381 | $9.93 | −$23.6K | 7,715 |
| Car Bruce | Chief Scientific Officer | Jan 05 | Exercise / conversion · M | +4,750 | — | — | 10,096 |
| Gentile Kimberly | SVP, Clinical Operations | Jan 05 | Withheld — tax / exercise cost · F | −1,956 | $9.93 | −$19.4K | 99,557 |
| Gentile Kimberly | SVP, Clinical Operations | Jan 05 | Exercise / conversion · M | +3,750 | — | — | 101,513 |
| Buten Matthew | Chief Financial Officer | Jan 05 | Withheld — tax / exercise cost · F | −2,594 | $9.93 | −$25.8K | 195,652 |
| Buten Matthew | Chief Financial Officer | Jan 05 | Exercise / conversion · M | +4,250 | — | — | 198,246 |
| Coric Vlad | Chief Executive Officer | Jan 05 | Withheld — tax / exercise cost · F | −7,430 | $9.93 | −$73.8K | 1,803,968 |
| Coric Vlad | Chief Executive Officer | Jan 05 | Exercise / conversion · M | +14,250 | — | — | 1,811,398 |
| Clark George C. | VP, Chief Accounting Officer | Nov 17 | Open-market buy · P | +17,000 | $8.52 | +$145K | 20,000 |
| Childs John W | Director | Nov 13 | Open-market buy · P | +3,333,333 | $7.50 | +$25M | 5,653,904 |
| Coric Vlad | Chief Executive Officer | Nov 13 | Open-market buy · P | +333,333 | $7.50 | +$2.5M | 740,546 |
| Coric Vlad | Chief Executive Officer | Nov 13 | Open-market buy · P | +333,333 | $7.50 | +$2.5M | 1,195,275 |
| Bailey Gregory | Director | Nov 13 | Open-market buy · P | +400,000 | $7.50 | +$3M | 2,020,071 |
| Childs John W | Director | Mar 04 | Open-market buy · P | +28,400 | $30.43 | +$864K | 2,323,971 |
| Clark George C. | VP, Chief Accounting Officer | Jan 05 | Withheld — tax / exercise cost · F | −1,117 | $38.64 | −$43.2K | 65,051 |
| Clark George C. | VP, Chief Accounting Officer | Jan 05 | Exercise / conversion · M | +2,500 | — | — | 66,168 |
Loading...